Who owns Infinity Pharmaceuticals?

Key details on Infinity Pharmaceuticals (Ticker: INFI)

Who owns Infinity Pharmaceuticals?

Is INFI a good stock to own? Find out who bought Infinity Pharmaceuticals, who sold Infinity Pharmaceuticals (INFI) stock, and who holds a large position in Infinity Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Vanguard 4.82M $67.42M March 31, 2015
OrbiMed Advisors 4.26M $59.62M March 31, 2015
Deerfield Management Company 3.97M $55.47M March 31, 2015
GOLDMAN SACHS 3.69M $51.54M March 31, 2015
S.A.C. Capital Advisors 3.41M $40.56M March 31, 2014
Perceptive Advisors 3.25M $157.49M March 31, 2013
Quogue Capital 2.91M $101.68M Dec. 31, 2012
BB Biotech AG 2.62M $36.64M March 31, 2015
BlackRock Fund Advisors 2.58M $36.10M March 31, 2015
FMR 2.41M $33.66M March 31, 2015
STATE STREET CORPORATION 2.35M $32.85M March 31, 2015
Point72 Asset Management 2.20M $29.52M Sept. 30, 2014
BVF 2.18M $19.31M Dec. 31, 2011
Wellington Management Company 1.99M $27.85M March 31, 2015
Broadfin Capital 1.44M $425.27M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.44M $20.07M March 31, 2015
QVT Financial 1.33M $23.12M Sept. 30, 2013
Consonance Capital 1.26M $15.01M March 31, 2014
BlackRock Advisors 1.17M $20.36M Sept. 30, 2013
Dr. Jeffrey R. Jay, M.D. 1.10M $14.76M Sept. 30, 2014
Baker Bros. Advisors 1.02M $16.46M June 30, 2013
Visium Asset Management 951852 $13.15M Dec. 31, 2013
HealthCor Management 923600 $11.77M June 30, 2014
T. Rowe Price Associates 892070 $15.07M Dec. 31, 2014
Millennium Management 891222 $12.46M March 31, 2015
Charles Schwab Investment Management 826210 $11.55M March 31, 2015
SUSQUEHANNA INTERNATIONAL 822165 $11.03M Sept. 30, 2014
Oxford Asset Management 811331 $13.18M June 30, 2013
Ameriprise Financial 777357 $9.24M March 31, 2014

Who sold Infinity Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company Sept. 30, 2011 868259 $5.79M
NEA Management Company June 30, 2011 876492 $7.24M